This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
- Jun 23, 2021Company Confident Evidence Regarding Only Remaining Claim Will Show Mylan's Actions Were Lawful and Pro-competitive
- May 6, 2021Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities WorldwideNew company highlights patients, holistic approach to providing access to medicine, and path to further progress